Arkolith/Insider Trading/CTSO/Form 4

Sobel Alan D.

DirectorCytosorbents Corp (CTSO) · full profile →Form 4 · filed Jan 22, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 17, 2025Option exercise(X)22K$1.00$22K124K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 17, 2025Other(J)22K——22K
Jan 17, 2025Other(J)22K——22K
Jan 17, 2025Option exercise(X)22K—$00

Transaction Codes

X
Exercise of in-the-money derivative
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-005354) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML